Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
2.
Mol Genet Metab ; 70(3): 214-8, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10924276

ABSTRACT

Graves disease is complex autoimmune thyrotoxicosis. A number of genes may contribute to the development of the disorder. Some of them may be genes that encode cytotoxic T-lymphocyte-associated serine esterase-4 (CTLA4), subunit 2 of large multifunctional protease (LMP2), thyroid-stimulating hormone receptor (TSHR), and interleukin 1 receptor antagonist (IL1RN). We studied polymorphism of Ala17Thr CTLA4, H60R LMP2, Pro52Thr TSHR, and IL1RN-VNTR in healthy controls (n = 93) and patients with Graves disease (n = 78) using PCR. To study CTLA4, H60R, and TSHR polymorphism, PCR products were digested with MboI, Hin6I and PsyI, respectively. Comparative analysis using chi(2) test showed significant differences in allele and genotype frequency of Ala17Thr polymorphic marker between the two groups studied. Thus, the CTLA4 gene may be involved in the pathogenesis of Graves disease in a Moscow population.


Subject(s)
Antigens, Differentiation/genetics , Graves Disease/genetics , Immunoconjugates , Polymorphism, Genetic/genetics , Receptors, Thyrotropin/genetics , Sialoglycoproteins/genetics , Viral Matrix Proteins/genetics , Abatacept , Adult , Alleles , Amino Acid Substitution , Antigens, CD , CTLA-4 Antigen , DNA/analysis , Female , Gene Frequency , Genetic Markers , Genotype , Humans , Interleukin 1 Receptor Antagonist Protein , Male , Mutation , Polymerase Chain Reaction , Restriction Mapping
SELECTION OF CITATIONS
SEARCH DETAIL
...